CXCL12-H
|
HCC
|
CXCL12-H
|
HCC
|
T-lymphocyte cell therapy Sensitive: C3 – Early Trials
|
T-lymphocyte cell therapy Sensitive: C3 – Early Trials
|
CXCL12-H
|
RCC
|
CXCL12-H
|
RCC
|
pazopanib Resistant: C3 – Early Trials
|
pazopanib Resistant: C3 – Early Trials
|